These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18506387)

  • 21. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
    Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
    J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.
    Aymard G; Berlin I; de Brettes B; Diquet B
    Fundam Clin Pharmacol; 2003 Aug; 17(4):473-81. PubMed ID: 12914551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
    Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
    Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system.
    Laping NJ; Ramirez VD
    Pharmacol Biochem Behav; 1988 Jan; 29(1):59-62. PubMed ID: 3127835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
    Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apomorphine sensitization: evoking conditions, context dependence, effect persistence and conditioned nature.
    Keller S; Delius JD; Acerbo MJ
    Behav Pharmacol; 2002 May; 13(3):189-201. PubMed ID: 12122309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.
    Schüle C; Baghai T; Schmidbauer S; Bidlingmaier M; Strasburger CJ; Laakmann G
    Psychoneuroendocrinology; 2004 Feb; 29(2):185-200. PubMed ID: 14604600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by sudden darkness of apomorphine-induced behavioral responses.
    Nasello AG; Sassatani AS; Ferreira FS; Felicio LF; Tieppo CA
    Physiol Behav; 2003 Apr; 78(4-5):521-8. PubMed ID: 12782204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients.
    Duval F; Mokrani MC; Macher JP; Crocq MA; Castro JO; Bailey P; Lataste X
    Psychopharmacology (Berl); 1993; 110(1-2):177-80. PubMed ID: 7870880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization to apomorphine in pigeons: a multifactorial conditioning process.
    Delius JD; Acerbo MJ; Krug I; Lee J; Leydel R
    Behav Pharmacol; 2015 Feb; 26(1-2):139-58. PubMed ID: 25192069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Video assessment of yawning induced by sublingual apomorphine in migraine.
    Del Bene E; Poggioni M; De Tommasi F
    Headache; 1994 Oct; 34(9):536-8. PubMed ID: 8002329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in medial frontal cortex ERK activation following the induction of apomorphine sensitization.
    Sanguedo FV; Dias FR; Bloise E; Cespedes IC; Giraldi-Guimarães A; Samuels RI; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2014 Mar; 118():60-8. PubMed ID: 24380761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-trial low dose apomorphine prevents the development of morphine sensitization.
    de Mello Bastos JM; Leite JB; Samuels RI; Carey RJ; Carrera MP
    Behav Brain Res; 2020 Feb; 380():112398. PubMed ID: 31790782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
    Maccario M; Veldhuis JD; Broglio F; Vito LD; Arvat E; Deghenghi R; Ghigo E
    Eur J Endocrinol; 2002 Mar; 146(3):310-8. PubMed ID: 11888836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa.
    Miljic D; Pekic S; Djurovic M; Doknic M; Milic N; Casanueva FF; Ghatei M; Popovic V
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1491-5. PubMed ID: 16449333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
    Lal S; Ackman D; Thavundayil JX; Kiely ME; Etienne P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):695-9. PubMed ID: 6531440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.